GGrantIndex
Sort

17,828 grants matching crispr

CRK regulation of ribosome biogenesis and craniofacial development

$31,695
Mason McCool · Yale University · F31 · FY2021 · DE

Elucidating antiviral defenses against diverse immunodeficiency viruses using a novel, high-throughput CRISPR/Cas9 screening method.

$31,694
Daniel Poston · Weill Medical Coll Of Cornell Univ · F30 · FY2023 · AI

Mechanisms and functions of CRISPR-Casautoregulation in bacterial immunity and pathogenesis

$31,660
Rachael Workman Sparklin · Johns Hopkins University · F31 · FY2023 · GM

EGFR T790M-mediated drug resistance in non-small cell lung cancer

$31,649
Pinar Ozden Eser · Harvard Medical School · F31 · FY2017 · CA

Mechanisms of Transcriptional Regulation by MTG16 in the Intestine

$31,648
Rachel Elizabeth Brown · Vanderbilt University · F30 · FY2019 · DK

Hypoxia-induced mutagenesis and resistance to targeted therapy

$31,644
Marco Maruggi · Sanford Burnham Prebys Medical Discovery Institute · F31 · FY2017 · CA

Optimization of Polymeric Nanoparticles Encapsulating Peptide Nucleic Acids for In Utero Gene Editing of the Fetal Brain.

$31,637
Anna Y Lynn · Yale University · F30 · FY2022 · HD

Single nucleotide variations account for strain specific virulence changes in Cryptococcus neoformans

$31,636
Katrina M Jackson · University Of Minnesota · F31 · FY2020 · AI

Investigating the Epigenetic Regulation of Imprinted Gene Grb10 in Neurodevelopment

$31,614
Aimee Juan · University Of Pennsylvania · F31 · FY2018 · HD

Ferroptosis as a Modulator of Checkpoint Inhibitor Immunotherapy

$31,607
Ronan Christopher Talty · Yale University · F30 · FY2022 · CA

Deciphering the Mechanism of Revertant Mosaicism and Cellular Competition in Ichthyosis with Confetti

$31,607
Diana Alexandra Yanez · Yale University · F31 · FY2022 · AR

Activation of non-apoptotic cell death by the DNA damage response

$31,506
Megan Elizabeth Honeywell · Univ Of Massachusetts Med Sch Worcester · F31 · FY2022 · CA

Isolating Ventricular Progenitor Cells with an Irx4 Reporter, Nanoflares, and Domain Antibodies

$31,482
Mitch Biermann · University Of Wisconsin-Madison · F30 · FY2016 · HL

Cell Subtype Transcriptional Role of Nab2 in Cocaine Self Administration

$31,473
Eric Y Choi · University Of Maryland Baltimore · F31 · FY2022 · DA

The APOBEC in APOBEC mutagenesis

$31,457
Matthew C Jarvis · University Of Minnesota · F31 · FY2020 · CA

Impact of Gut Bacterial Interactions on the Response to Fiber-Based Prebiotics

$31,454
Zachary Walter Beller · Washington University · F30 · FY2020 · DK

Elucidating the role of Enolase 2 during HCMV infection

$31,376
Isreal Moreno · University Of Rochester · F31 · FY2022 · AI

In vivo Genome Editing for Hereditary Tyrosinemia Type I Using a Compact, Hyper-accurate Cas9 from Neisseria meningitidis

$31,366
Raed Ibraheim · Univ Of Massachusetts Med Sch Worcester · F31 · FY2018 · DK

Understanding the role of PRDM1 in limb development and split hand/foot malformation.

$31,364
Brittany Truong · University Of Colorado Denver · F31 · FY2022 · HD

Elucidating a physiological role for ARRDC-1 Mediated Microvesicles (ARMMs): A versatile platform for the delivery of biological therapeutics

$31,300
Joseph Beyene · Harvard School Of Public Health · F31 · FY2020 · GM

Dynamic interplay of eukaryotic translation and mRNA decay

$31,224
Michael R Lawson · Stanford University · K99 · FY2023 · GM

Identifying Novel Target Pathways and Therapies in Castration Resistant Prostate Cancer

$31,176
Marisa Sanchez · Sanford Burnham Prebys Medical Discovery Institute · F31 · FY2016 · CA

Hypoxia-induced mutagenesis and resistance to targeted therapy

$31,176
Marco Maruggi · Sanford Burnham Prebys Medical Discovery Institute · F31 · FY2016 · CA

Mechanisms of Transcriptional Regulation by MTG16 in the Intestine

$31,156
Rachel Elizabeth Brown · Vanderbilt University · F30 · FY2018 · DK

beta1 integrin/c-Met: a receptor complex driving invasive resistance to anti-angiogenic therapy in glioblastoma

$31,147
Arman Jahangiri · University Of California, San Francisco · F31 · FY2017 · CA